Thickened endometrium caused by tamoxifen returns to normal following tamoxifen cessation

Breast

Volumn 9, Issue 3, 2000, Pages 156-157

  Love, C D B ^a   Dixon, J M ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; DRUG WITHDRAWAL; ENDOMETRIUM ATROPHY; FEMALE; HUMAN; PRIORITY JOURNAL; ULTRASOUND;

EID: 0034076804     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.1999.0160     Document Type: Article

References (7)

1. Hann L E, Giess C S, Bach A M, Tao Y, Baum H J, Barakat R R. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings. AJR. 168:1997;657-661.
2. Bertelli G, Venturini M, Del Mastro L. Tamoxifen and the endometrium: findings of pelvic ultrasound examination and endometrial biopsy in asymptomatic breast cancer patients. Breast Cancer Res Treat. 47:1998;41-46.
3. Mourits M J, Van Der See A G, Willemse P H, Ten Hoor K A, Hollema H, De Vries E G. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen. Gynecol Oncol. 73:1999;21-26.
4. Bornstein J, Auslender R, Pascal B, Gutterman E, Isakov D, Abramovici H. Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen. J Reprod Med. 39:1994;674-678.
5. Love C D B, Muir B B, Scrimgeour J B, Leonard R C F, Dillon P, Dixon J M. An investigation of endometrial abnormalities in asymptomatic women on tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol. 7:1999;2050-2054.
6. Aleem F A, Predanic M. Endometrial changes in patients on tamoxifen. Lancet. 346:1995;1292.
7. Cohen I, Rosen D J, Tepper R. Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen. J Ultrasound Med. 5:1993;275-280.